Gts Securities »

Biogen Idec shares owned by Gts Securities

Quarter-by-quarter ownership of Biogen Idec (BIIB) shares owned by Gts Securities from 13F filings

Historical chart of Gts Securities investment in Biogen Idec

Tip: Access up to 7 years of quarterly data

All positions including Biogen Idec held by Gts Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biogen Idec by Gts Securities

Quarter filed Position value Share count Share price at filing
2024-03-31 $7.2M 34k 215.63
2023-12-31 $26M 101k 258.77
2023-09-30 $27M 106k 257.01
2023-06-30 $3.2M 11k 284.85

More positions owned by Gts Securities

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
NVIDIA Corporation Put Option (NVDA)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Microsoft Corporation Put Option (MSFT)
Meta Platforms Cl A Put Option (META)
Amazon Put Option (AMZN)
Netflix Put Option (NFLX)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Tesla Motors Put Option (TSLA)
Alphabet Cap Stk Cl C Put Option (GOOG)
Apple Put Option (AAPL)
Alphabet Cap Stk Cl A Put Option (GOOGL)
Broadcom Put Option (AVGO)
Advanced Micro Devices Put Option (AMD)
Microstrategy Cl A New Put Option (MSTR)

View all positions for Gts Securities

Top funds holding Biogen Idec

Vanguard Group
PRIMECAP Management Company
BlackRock
Wellington Management Company
T. Rowe Price Investment Management
Jpmorgan Chase & Co
Geode Capital Management
Van Eck Associates Corp.
Morgan Stanley
T. Rowe Price Associates
ClearBridge Advisors
Legal & General Group
Northern Trust
Bank of New York Mellon
Dimensional Fund Advisors

View all funds holding Biogen Idec